[Drug therapy in myasthenia gravis].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D009388:Neostigmine; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide
Medikamentell behandling av myasthenia gravis